Endocannabinoid system, stress and HPA axis.

[1]  T. Beißbarth,et al.  Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders , 2018, CNS neuroscience & therapeutics.

[2]  F. Correa,et al.  Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress , 2018, Psychoneuroendocrinology.

[3]  J. Leza,et al.  Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex , 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[4]  M. Eder,et al.  Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus. , 2017, Journal of psychiatric research.

[5]  V. Di Marzo,et al.  Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) , 2017, Pharmacological research.

[6]  M. López-Gallardo,et al.  Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences , 2017, Pharmacology Biochemistry and Behavior.

[7]  P. Willner,et al.  The chronic mild stress (CMS) model of depression: History, evaluation and usage , 2016, Neurobiology of Stress.

[8]  J. Deussing,et al.  Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function , 2016, Psychoneuroendocrinology.

[9]  J. Buckner,et al.  Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems. , 2016, The American journal on addictions.

[10]  N. Chen,et al.  Effects of chronic mild stress on behavioral and neurobiological parameters — Role of glucocorticoid , 2016, Hormones and Behavior.

[11]  S. Thompson,et al.  Corticosterone mediates the synaptic and behavioral effects of chronic stress at rat hippocampal temporoammonic synapses. , 2015, Journal of neurophysiology.

[12]  C. Wotjak,et al.  2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons , 2015, Psychopharmacology.

[13]  R. McLaughlin,et al.  Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety , 2015, The Journal of Neuroscience.

[14]  J. D. McGaugh,et al.  Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training , 2014, Proceedings of the National Academy of Sciences.

[15]  F. Drago,et al.  The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. , 2014, Pharmacological research.

[16]  L. Marnett,et al.  Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation , 2014, Translational Psychiatry.

[17]  J. Leza,et al.  Regulatory role of the cannabinoid CB2 receptor in stress‐induced neuroinflammation in mice , 2014, British journal of pharmacology.

[18]  J. Bains,et al.  Experience Salience Gates Endocannabinoid Signaling at Hypothalamic Synapses , 2014, The Journal of Neuroscience.

[19]  Ling Liu,et al.  Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system. , 2014, Journal of psychiatric research.

[20]  Vincenzo Micale,et al.  Therapeutic potential of cannabinoids in schizophrenia. , 2014, Recent patents on CNS drug discovery.

[21]  Livio Luongo,et al.  Endocannabinoids and neuropathic pain: focus on neuron–glia and endocannabinoid–neurotrophin interactions , 2014, The European journal of neuroscience.

[22]  J. Long,et al.  Monoacylglycerol Lipase Inhibition Blocks Chronic Stress-Induced Depressive-Like Behaviors via Activation of mTOR Signaling , 2014, Neuropsychopharmacology.

[23]  L. Spear,et al.  Environmental manipulations alter age differences in attribution of incentive salience to reward-paired cues , 2013, Behavioural Brain Research.

[24]  S. Chattarji,et al.  Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure , 2013, Molecular Psychiatry.

[25]  M. Hill,et al.  Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats , 2013, Neuroscience.

[26]  V. Micale,et al.  Leading compounds for the validation of animal models of psychopathology , 2013, Cell and Tissue Research.

[27]  S. Salomone,et al.  Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant. , 2013, The international journal of neuropsychopharmacology.

[28]  C. Silvestri,et al.  The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. , 2013, Cell metabolism.

[29]  C. Wotjak,et al.  Endocannabinoid system and mood disorders: priming a target for new therapies. , 2013, Pharmacology & therapeutics.

[30]  R. McLaughlin,et al.  Upregulation of CB1 receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure , 2013, Behavioural Brain Research.

[31]  R. McLaughlin,et al.  Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway , 2012, European Neuropsychopharmacology.

[32]  M. Häring,et al.  Genetic Dissection of the Role of Cannabinoid Type-1 Receptors in the Emotional Consequences of Repeated Social Stress in Mice , 2012, Neuropsychopharmacology.

[33]  F. Piscitelli,et al.  "Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control. , 2012, ACS chemical neuroscience.

[34]  C. Hillard,et al.  Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol , 2012, Neuroscience.

[35]  B. McEwen,et al.  Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice , 2012, Neuroscience.

[36]  J. D. McGaugh,et al.  Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory , 2012, Proceedings of the National Academy of Sciences.

[37]  B. Gorzalka,et al.  Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation , 2012, Journal of psychopharmacology.

[38]  M. Bramini,et al.  Chronic Stress Induces Sex-Specific Alterations in Methylation and Expression of Corticotropin-Releasing Factor Gene in the Rat , 2011, PloS one.

[39]  R. McLaughlin,et al.  Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response , 2011, The Journal of Neuroscience.

[40]  B. Czéh,et al.  Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats , 2011, Brain Research Bulletin.

[41]  C. Wotjak,et al.  The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors , 2011, Front. Behav. Neurosci..

[42]  J. Herman,et al.  Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. , 2010, Endocrinology.

[43]  F. Drago,et al.  The β3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes , 2010, European Neuropsychopharmacology.

[44]  Jaclyn I. Wamsteeker,et al.  Repeated Stress Impairs Endocannabinoid Signaling in the Paraventricular Nucleus of the Hypothalamus , 2010, The Journal of Neuroscience.

[45]  J. Manzanares,et al.  Depression‐resistant endophenotype in mice overexpressing cannabinoid CB2 receptors , 2010, British journal of pharmacology.

[46]  D. Centonze,et al.  Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition , 2010, Molecular Pharmacology.

[47]  C. Hillard,et al.  Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress , 2010, Neuropsychopharmacology.

[48]  F. Drago,et al.  Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. , 2010, Pharmacological research.

[49]  R. McLaughlin,et al.  Endogenous cannabinoid signaling is essential for stress adaptation , 2010, Proceedings of the National Academy of Sciences.

[50]  V. Viau,et al.  A Comparison of Two Repeated Restraint Stress Paradigms on Hypothalamic‐Pituitary‐Adrenal Axis Habituation, Gonadal Status and Central Neuropeptide Expression in Adult Male Rats , 2010, Journal of neuroendocrinology.

[51]  S. Bornstein,et al.  Expression and Function of Endocannabinoid Receptors in the Human Adrenal Cortex , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[52]  F. Holsboer,et al.  Dynamic DNA methylation programs persistent adverse effects of early-life stress , 2009, Nature Neuroscience.

[53]  M. McCarthy,et al.  Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats , 2009, Behavioural Brain Research.

[54]  R. Capasso,et al.  Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. , 2009, Trends in pharmacological sciences.

[55]  V. Marzo,et al.  Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems , 2009, Neurobiology of Disease.

[56]  S. Floresco,et al.  Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic-Pituitary-Adrenal Axis , 2009, Neuropsychopharmacology.

[57]  K. Mackie,et al.  Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala , 2009, Neuropsychopharmacology.

[58]  H. Covington,et al.  Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. , 2008, Pharmacology and Therapeutics.

[59]  C. Large,et al.  Chronic stress‐induced alterations in amygdala responsiveness and behavior – modulation by trait anxiety and corticotropin‐releasing factor systems , 2008, The European journal of neuroscience.

[60]  G. Uhl,et al.  Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression , 2008, Annals of the New York Academy of Sciences.

[61]  F. Drago,et al.  Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions , 2008, Pharmacology Biochemistry and Behavior.

[62]  R. McLaughlin,et al.  Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment , 2008, Journal of neurochemistry.

[63]  D. Centonze,et al.  Chronic Psychoemotional Stress Impairs Cannabinoid-Receptor-Mediated Control of GABA Transmission in the Striatum , 2008, The Journal of Neuroscience.

[64]  Leyu Shi,et al.  Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice , 2008, Neuropharmacology.

[65]  Jiang-Ning Zhou,et al.  Mifepristone Repairs Region-Dependent Alteration of Synapsin I in Hippocampus in Rat Model of Depression , 2007, Neuropsychopharmacology.

[66]  R. Mangieri,et al.  Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress , 2007, Biological Psychiatry.

[67]  F. Drago,et al.  Endocannabinoids and neurodegenerative diseases. , 2007, Pharmacological research.

[68]  M. Häring,et al.  Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice , 2007, Neuroscience.

[69]  Masahiko Watanabe,et al.  Distribution of type 1 cannabinoid receptor (CB1)‐immunoreactive axons in the mouse hypothalamus , 2007, The Journal of comparative neurology.

[70]  D. Cota,et al.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. , 2007, Endocrinology.

[71]  E. V. Bockstaele,et al.  Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex , 2007, Brain Research.

[72]  A. Armario.  The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors? , 2006, CNS & neurological disorders drug targets.

[73]  S. Di,et al.  Opposing Crosstalk between Leptin and Glucocorticoids Rapidly Modulates Synaptic Excitation via Endocannabinoid Release , 2006, The Journal of Neuroscience.

[74]  Sung-jin Kim,et al.  Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats , 2006, Neuropharmacology.

[75]  G. Uhl,et al.  Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain , 2006, Brain Research.

[76]  James P. Herman,et al.  Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[77]  Haiyun Xu,et al.  Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress , 2005, Brain Research.

[78]  K. Mackie,et al.  Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .

[79]  M. Dallman.  Fast glucocorticoid actions on brain: Back to the future , 2005, Frontiers in Neuroendocrinology.

[80]  S. Di,et al.  Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. , 2005, Endocrinology.

[81]  F. Drago,et al.  Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). , 2005, European journal of pharmacology.

[82]  K. Mackie.  Cannabinoid receptor homo- and heterodimerization. , 2005, Life sciences.

[83]  J. Crystal,et al.  An endocannabinoid mechanism for stress-induced analgesia , 2005, Nature.

[84]  F. Holsboer,et al.  Stress and the brain: from adaptation to disease , 2005, Nature Reviews Neuroscience.

[85]  B. Gorzalka,et al.  Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress , 2005, Neuropsychopharmacology.

[86]  C. Hillard,et al.  Inhibition of restraint stress‐induced neural and behavioural activation by endogenous cannabinoid signalling , 2005, The European journal of neuroscience.

[87]  S. D. de Boer,et al.  Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning , 2005, Neuroscience & Biobehavioral Reviews.

[88]  W. Cullinan,et al.  Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. , 2004, Endocrinology.

[89]  C. Wotjak,et al.  The hypothalamic–neurohypophysial system regulates the hypothalamic–pituitary–adrenal axis under stress: An old concept revisited , 2004, Frontiers in Neuroendocrinology.

[90]  F. Drago,et al.  Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. , 2003, European journal of pharmacology.

[91]  Lin Lu,et al.  Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review , 2003, Neuroscience & Biobehavioral Reviews.

[92]  C. Flachskamm,et al.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. , 2003, The Journal of clinical investigation.

[93]  Dennis C. Choi,et al.  Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness , 2003, Frontiers in Neuroendocrinology.

[94]  S. Di,et al.  Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism , 2003, The Journal of Neuroscience.

[95]  L. Iversen,et al.  Cannabis and the brain. , 2003, Brain : a journal of neurology.

[96]  T. Arzberger,et al.  Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. , 2001, The Journal of clinical endocrinology and metabolism.

[97]  F. Drago,et al.  Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? , 2001, European Neuropsychopharmacology.

[98]  E. Williamson,et al.  Cannabinoids in Clinical Practice , 2000, Drugs.

[99]  G. Marsicano,et al.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.

[100]  W. Scherbaum,et al.  Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. , 1998, Endocrine reviews.

[101]  M. Le Moal,et al.  The role of stress in drug self-administration. , 1998, Trends in pharmacological sciences.

[102]  F. Antoni.  Vasopressinergic Control of Pituitary Adrenocorticotropin Secretion Comes of Age , 1993, Frontiers in Neuroendocrinology.

[103]  Richard Muscat,et al.  Chronic mild stress-induced anhedonia: A realistic animal model of depression , 1992, Neuroscience & Biobehavioral Reviews.

[104]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[105]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[106]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[107]  L. Swanson,et al.  Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.

[108]  J. D. McGaugh,et al.  Depletion of adrenal catecholamines alters the amnestic effect of amygdala stimulation , 1985, Behavioural Brain Research.

[109]  K. Miczek,et al.  Opioid-like analgesia in defeated mice. , 1982, Science.

[110]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[111]  J. Horáček,et al.  Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? , 2017, Pharmacological research.

[112]  B. Lutz,et al.  Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain , 2015, Neuropsychopharmacology.

[113]  F. Drago,et al.  Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence , 2015 .

[114]  C. Wotjak,et al.  Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. , 2008, Progress in brain research.

[115]  E. D. de Kloet,et al.  Hormones, brain and stress. , 2003, Endocrine regulations.

[116]  D. McArthur,et al.  Comparison of electromyographic response patterns during posture and stress tasks in chronic low back pain patterns and control. , 1986, Journal of psychosomatic research.